Cuvposa Dosage
Generic name: GLYCOPYRROLATE 1mg in 5mL
Dosage form: oral liquid
Drug class: Anticholinergics / antispasmodics
Medically reviewed by Drugs.com. Last updated on Dec 19, 2024.
CUVPOSA must be measured and administered with an accurate measuring device.
Initiate dosing at 0.02 mg/kg orally three times daily and titrate in increments of 0.02 mg/kg every 5-7 days based on therapeutic response and adverse reactions. The maximum recommended dosage is 0.1 mg/kg three times daily not to exceed 1.5-3 mg per dose based upon weight. For greater detail, see Table 1.
During the four-week titration period, dosing can be increased with the recommended dose titration schedule while ensuring that the anticholinergic adverse events are tolerable. Prior to each increase in dose, review the tolerability of the current dose level with the patient's caregiver.
CUVPOSA should be dosed at least one hour before or two hours after meals.
The presence of high fat food reduces the oral bioavailability of CUVPOSA if taken shortly after a meal.
Weight | Dose Level 1 | Dose Level 2 | Dose Level 3 | Dose Level 4 | Dose Level 5 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
kg | lbs | (~0.02 mg/kg) | (~0.04 mg/kg) | (~0.06 mg/kg) | (~0.08 mg/kg) | (~0.1 mg/kg) | |||||
13-17 | 27-38 | 0.3 mg | 1.5 mL | 0.6 mg | 3 mL | 0.9 mg | 4.5 mL | 1.2 mg | 6 mL | 1.5 mg | 7.5 mL |
18-22 | 39-49 | 0.4 mg | 2 mL | 0.8 mL | 4 mL | 1.2 mg | 6 mL | 1.6 mg | 8 mL | 2.0 mg | 10 mL |
23-27 | 50-60 | 0.5 mg | 2.5 mL | 1.0 mg | 5 mL | 1.5 mg | 7.5 mL | 2.0 mg | 10 mL | 2.5 mg | 12.5 mL |
28-32 | 61-71 | 0.6 mg | 3 mL | 1.2 mg | 6 mL | 1.8 mg | 9 mL | 2.4 mg | 12 mL | 3.0 mg | 15 mL |
33-37 | 72-82 | 0.7 mg | 3.5 mL | 1.4 mg | 7 mL | 2.1 mg | 10.5 mL | 2.8 mg | 14 mL | 3.0 mg | 15 mL |
38-42 | 83-93 | 0.8 mg | 4 mL | 1.6 mg | 8 mL | 2.4 mg | 12 mL | 3.0 mg | 15 mL | 3.0 mg | 15 mL |
43-47 | 94-104 | 0.9 mg | 4.5 mL | 1.8 mg | 9 mL | 2.7 mg | 13.5 mL | 3.0 mg | 15 mL | 3.0 mg | 15 mL |
≥48 | ≥105 | 1.0 mg | 5 mL | 2.0 mg | 10 mL | 3.0 mg | 15 mL | 3.0 mg | 15 mL | 3.0 mg | 15 mL |
More about Cuvposa (glycopyrrolate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: anticholinergics/antispasmodics
- Breastfeeding
- En español
Patient resources
Other brands
Robinul, Seebri Neohaler, Lonhala Magnair, Dartisla ODT, ... +2 more
Professional resources
Other brands
Robinul, Seebri Neohaler, Lonhala Magnair, Dartisla ODT, Glyrx-PF
Related treatment guides
See also:
Seebri Neohaler
Seebri Neohaler (glycopyrrolate) is used to treat COPD. Includes Seebri Neohaler side effects ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
AtroPen
AtroPen is used for anticholinesterase poisoning, AV Heart Block, bradyarrhythmia
Bentyl
Bentyl is used to treat functional bowel or irritable bowel syndrome. Bentyl may also be used for ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.